CVS Group plc Exercise of Options, PDMR Dealing and TVR (0092P)
13 Octubre 2021 - 12:01PM
UK Regulatory
TIDMCVSG
RNS Number : 0092P
CVS Group plc
13 October 2021
13 October 2021
CVS Group Plc
("CVS", the "Company" or the "Group")
Exercise of Options, PDMR Dealing and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary
services, announces that on 13 October 2021, options over a total
of 97,491 new ordinary shares of 0.2 pence each (the "New Shares")
were exercised under the CVS Group Long Term Incentive Plan (LTIP)
12 (2018/2021), at an exercise price of 0.2 pence.
Richard Fairman, Chief Executive Officer, and Ben Jacklin, Chief
Operating Officer, exercised options over 30,969 and 6,194 ordinary
shares of 0.2p each in the Company respectively ("Ordinary
Shares"). The balance of the options were exercised by certain
other employees and former employees of the Company.
On 13 October 2021, the Company was notified that, on that date,
Richard Fairman and Ben Jacklin sold 14,601 and 2,921 Ordinary
Shares respectively at a price of GBP24.2215 per Ordinary Share.
These sale amounts are sufficient to meet the costs of exercise
incurred by the PDMR option holders, including personal
taxation.
Following their respective option exercises and their sales of a
portion of the new shares arising, Richard Fairman holds a
beneficial interest in 27,818 Ordinary Shares in the Company,
representing approximately 0.039 per cent of the total voting
rights of the Company following the issue of the New Shares, and
Ben Jacklin holds a beneficial interest in 4,709 Ordinary Shares in
the Company, representing approximately 0.007 per cent of the total
voting rights of the Company, calculated on the same basis.
Application has been made for the New Shares, which rank pari
passu in all respects with the Company's existing Ordinary Shares,
to be admitted to trading on AIM which is expected to occur on
Tuesday 19 October, 2021.
Following the issue of the New Shares, the Company has a total
issued share capital of 70,866,133 Ordinary Shares each carrying
one voting right. The Company holds no Ordinary Shares in treasury.
Therefore, following the issue of the New Shares, the total number
of voting rights in the Company will be 70,866,133. This figure may
be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency Rules.
The notification below, made in accordance with the requirements
of the UK Market Abuse Regulation, provides further detail.
This announcement is released by CVS Group plc and contains
inside information for the purposes of the retained UK version of
the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"),
encompassing information relating to trading for the Company's
current financial year, and is disclosed in accordance with the
Company's obligations under UK MAR. This announcement is being made
on behalf of the Company by the director named below.
Contacts:
CVS Group plc via MHP Communications
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Singer Capital Markets (Nominated Adviser &
Broker) +44 20 7496 3000
Aubrey Powell / Jen Boorer / Rachel Hayes
MHP Communications (Financial PR) +44 20 3128 8549
Andrew Jaques / Rachel Mann / Charles Hirst
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Richard Fairman
-------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------
a) Position/status Chief Executive Officer
-------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name CVS Group plc
-------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
-------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description of the Ordinary shares of 0.2 pence each
financial instrument,
type of instrument
GB00B2863827
Identification code
-------------------------- ------------------------------------------
b) Nature of the transaction i) Exercise of options under LTIP
12
ii) Partial sale of ordinary shares
arising from exercise
-------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
i) Exercise price
of 0.2p 30,969
ii) GBP24.2215 14,601
----------
-------------------------- ------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
-------------------------- ------------------------------------------
e) Date of the transaction 13 October 2021
-------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
-------------------------- ------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Ben Jacklin
-------------------------- ------------------------------------------
2 Reason for the notification
----------------------------------------------------------------------
a) Position/status Chief Operating Officer
-------------------------- ------------------------------------------
b) Initial notification Initial Notification
/Amendment
-------------------------- ------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------
a) Name CVS Group plc
-------------------------- ------------------------------------------
b) LEI 213800J41XDQ2NX48O05
-------------------------- ------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------
a) Description of the Ordinary shares of 0.2 pence each
financial instrument,
type of instrument
GB00B2863827
Identification code
-------------------------- ------------------------------------------
b) Nature of the transaction i) Exercise of options under LTIP
12
ii) Partial sale of ordinary shares
arising from exercise
-------------------------- ------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
i) Exercise price
of 0.2p 6,194
ii) GBP24.2215 2,921
----------
-------------------------- ------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
-------------------------- ------------------------------------------
e) Date of the transaction 13 October 2021
-------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
-------------------------- ------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFLFIDIILVLIL
(END) Dow Jones Newswires
October 13, 2021 13:01 ET (17:01 GMT)
Cvs (LSE:CVSG)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Cvs (LSE:CVSG)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
